How MJFF “De-Risks” PD Drug Development Pipeline
17th January 2024 • The Michael J. Fox Foundation Parkinson's Podcast • The Michael J. Fox Foundation for Parkinson’s Research
00:00:00 00:33:09

Share Episode

Shownotes

One key pillar of The Michael J. Fox Foundation’s research strategy is a focus on “de-risking" potential treatments for Parkinson’s disease. This episode of our award-winning “Parkinson’s Science POV” series explains how lowering the risk associated with developing new therapies leads to a more robust pipeline of treatments. The episode details several recent successes of the strategy. 

Like our podcasts? Please consider leaving a rating or review and sharing the series with your network. https://apple.co/3p02Jw0 

Join a study today to help speed progress toward better treatments and a cure for Parkinson’s disease. To search for studies in your area, visit Fox Trial Finder at foxtrialfinder.org

Whether you have Parkinson’s or not, you can help move research forward. Join the study that’s changing everything. Find out more at michaeljfox.org/podcast-ppmi

Mentioned in this episode:

Our landmark study is examining the link between smell loss and risk for Parkinson’s disease in people of all backgrounds. If you’re age 60 or older and do not have Parkinson’s, you can help move this research forward by taking a free scratch-and-sniff test. Get yours today at mysmelltest.org/request.

Chapters

Video

More from YouTube